STOCK TITAN

PCRX (NASDAQ) shows 2,876 and 6,163 restricted shares vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PCRX submitted a Form 144 notice listing proposed transactions in Common Stock and showing scheduled restricted stock vesting dates. The excerpt lists 2,876 shares vesting on 06/12/2025 and 6,163 shares vesting on 06/09/2026. A broker entry names Fidelity Brokerage Services LLC.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notice lists planned dispositions tied to restricted stock vesting.

The excerpt records scheduled vesting of 2,876 shares on 06/12/2025 and 6,163 shares on 06/09/2026

These are compensation-related awards that appear in the seller disclosure and identify Fidelity Brokerage Services LLC as the broker. Timing and cash‑flow treatment for any sale are not detailed in the excerpt.

Restricted shares vesting (first tranche) 2,876 shares vesting on 06/12/2025, labeled Compensation
Restricted shares vesting (second tranche) 6,163 shares vesting on 06/09/2026, labeled Compensation
Listed numeric entry in securities row 39,347,924 appears in the securities information row (06/12/2026, NASDAQ)
Restricted Stock Vesting financial
"Common | 06/12/2025 | Restricted Stock Vesting"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Form 144 regulatory
"form_type: 144"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Fidelity Brokerage Services LLC other
"Common | Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares are listed for vesting for PCRX?

The excerpt shows 2,876 restricted shares vesting on 06/12/2025 and 6,163 restricted shares vesting on 06/09/2026. These entries are labeled as compensation-related restricted stock vesting in the table.

Which broker is named in the PCRX Form 144 excerpt?

The broker listed is Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI 02917. The entry appears in the securities information row associated with the proposed transactions.

Does the excerpt show shares sold in the past three months for PCRX?

The excerpt contains a heading for securities sold during the past three months but provides no specific transactions under that heading. The provided lines focus on scheduled restricted stock vesting entries.

Are the proposed sale amounts or proceeds disclosed in the excerpt for PCRX?

The excerpt lists share counts tied to vesting and a numeric row entry but does not state sale proceeds or pricing. The items shown are labeled as restricted stock vesting and compensation entries.